Research review
Does creatine help with menopause? What the research does and doesn't show
Trials in postmenopausal women found creatine plus resistance training produced small gains in lean mass and leg strength at 5 g/day or more, mixed results on bone density, and no research at all on hot flashes or mood — and almost none on perimenopause specifically.
The clearest research on creatine and menopause is about muscle and bone, not hot flashes or mood. A 2026 review of seven trials in postmenopausal women found small gains in lean mass and leg strength when creatine was combined with resistance training at 5 g/day or more — but no clear effect on bone density, and no trial has tested creatine against hot flashes, mood or other menopause symptoms directly.
What the evidence doesn't support
It doesn't support creatine as a way to ease hot flashes, night sweats, mood changes or other menopause symptoms — no trial in this literature has tested those outcomes. It doesn't reliably support a bone-density benefit either: most randomized trials, including a 2-year study, found no significant difference from placebo on bone mineral density; one 12-month trial found creatine slowed bone loss at one specific site but not others. And it doesn't say much about perimenopause specifically — almost every trial below studied women who were already postmenopausal, generally in their late 50s to 60s, so the transition years leading up to menopause are barely represented in this research.
What the trials found
The most complete picture comes from a 2026 systematic review and meta-analysis of 7 randomized, placebo-controlled trials (608 postmenopausal women, mean age ~62, trial lengths 12-104 weeks). Pooled across trials that combined creatine with resistance training, lean mass increased by 0.37 kg and leg-press one-rep-max strength increased by 7.5 kg compared with placebo. The review's own breakdown found the benefit showed up specifically when creatine was dosed at 5 g/day or more alongside resistance training; trials using 3 g/day or less without a training program showed no measurable effect. Bone density did not change significantly overall. Adverse events were mild and similar to placebo, and kidney function markers were unchanged.
Bone-specific trials are mixed. A 12-month randomized trial in 47 postmenopausal women (dose 0.1 g/kg/day, paired with supervised resistance training 3 days/week) found creatine slowed the rate of bone loss at the femoral neck specifically (-1.2% vs -3.9% with placebo) and increased a marker of bone-bending strength, along with a bigger bench-press strength gain than placebo — but found no group difference at other bone sites. A 2-year randomized trial in 200 postmenopausal women with osteopenia (3 g/day, without a described resistance-training component) found no significant effect on bone density, lean mass or muscle function at any site. A 1-year trial in 109 postmenopausal women testing a lower dose (1 g/day, also without training) likewise found no effect on bone density, body composition or muscle function. A meta-analysis of 5 trials in adults over 50 (193 participants, creatine plus resistance training vs. resistance training alone) found no significant effect on whole-body, hip, femoral neck or lumbar spine bone density.
A 2025 narrative review of creatine across women's life stages states plainly that data on perimenopausal women specifically "remains limited," and identifies it as a gap the field still needs to fill — it's a narrative overview of the existing literature, not a new trial itself.
| Study | Design | Dose | Population | Finding |
|---|---|---|---|---|
| Naddafha 2026 | Meta-analysis, 7 RCTs | Varied; benefit at ≥5 g/day + resistance training | 608 postmenopausal women | Lean mass +0.37 kg, leg-press +7.5 kg; bone density unchanged |
| Chilibeck 2015 | RCT, 12 months | 0.1 g/kg/day + resistance training | 47 postmenopausal women | Slowed femoral neck bone loss; other sites unchanged |
| Sales 2020 | RCT, 2 years | 3 g/day, no training arm | 200 postmenopausal women, osteopenia | No effect on bone density, lean mass or muscle function |
| Lobo 2015 | RCT, 1 year | 1 g/day, no training arm | 109 postmenopausal women | No effect on bone density or muscle function |
| Forbes 2018 | Meta-analysis, 5 RCTs | Varied + resistance training | 193 adults over 50 | No significant effect on bone density at any site |
Questions people ask
Does creatine help with menopause?
The trials above tested muscle mass, strength and bone density in postmenopausal women — not menopause symptoms like hot flashes or mood, which no trial in this literature has measured. On the outcomes that were tested, creatine combined with resistance training at 5 g/day or more produced small gains in lean mass and leg strength; effects on bone density were inconsistent and mostly null.
Does creatine help with perimenopause?
There's very little dedicated research here. A 2025 review of creatine in women's health specifically flags data on perimenopausal women as limited, and none of the randomized trials above enrolled women in that transition specifically — they studied women already postmenopausal.
Is creatine safe for menopausal women?
Across the trials above — including a 2-year study — adverse events with creatine were mild and not significantly different from placebo, and kidney function markers were unchanged. That's a safety observation from these specific trials, not a substitute for asking a doctor about your own health history, especially if you have a kidney condition; see who should not take creatine.
Does creatine help with bone density after menopause?
Mostly not, based on the trials above. Only one of four dedicated bone trials found a site-specific benefit (slower bone loss at the femoral neck); a 2-year trial and a meta-analysis of five trials found no significant effect on bone density anywhere measured.
When to talk to a doctor
Menopause symptoms that disrupt sleep, mood or daily life are worth discussing with a doctor, who can talk through options with an evidence base for those specific symptoms — creatine is not a treatment for menopause or for diagnosed osteoporosis or osteopenia. Anyone with a diagnosed bone condition, a kidney condition, or who takes prescription medication should talk to a doctor before adding creatine.
Related reading: creatine benefits: what the research does and doesn't show, how much creatine should you take a day?, and creatine and depression: what the research does and doesn't show for the separate question of mood.
Sources
- Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis A 2026 meta-analysis of 7 trials found creatine plus resistance training produced small but real gains in lean mass and leg strength in postmenopausal women, mainly at 5 g/day or more, with no clear effect on bone density and no more side effects than placebo.
- Effects of Creatine and Resistance Training on Bone Health in Postmenopausal Women A 12-month trial found creatine plus resistance training slowed bone loss specifically at the femoral neck and increased bench-press strength more than resistance training alone, in postmenopausal women — but found no difference at other bone sites.
- Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial A 2-year randomized trial found 3 g/day of creatine alone, without a training program, did not improve bone density, lean mass or muscle function in postmenopausal women with osteopenia.
- Effects of long-term low-dose dietary creatine supplementation in older women A 1-year trial of a low daily creatine dose (1 g/day), without a training program, found no effect on bone density, lean mass or muscle function in postmenopausal women.
- Creatine Supplementation During Resistance Training Does Not Lead to Greater Bone Mineral Density in Older Humans: A Brief Meta-Analysis A meta-analysis of 5 trials found adding creatine to a resistance-training program made no significant difference to bone density at any measured site in older or postmenopausal adults.
- Creatine in women's health: bridging the gap from menstruation through pregnancy to menopause A 2025 narrative review of creatine and women's health specifically flags data on perimenopausal women as limited and calls for more research there.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.